BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12799197)

  • 1. Co-effect of HLA-G1 and glycosyltransferases in reducing NK cell-mediated pig endothelial cell lysis.
    Miyagawa S; Nakai R; Matsunami K; Kusama T; Shirakura R
    Transpl Immunol; 2003; 11(2):147-53. PubMed ID: 12799197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of soluble HLA-G1 protecting porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
    Zeng MH; Fang CY; Wang SS; Zhu M; Xie L; Li R; Wang L; Wu XW; Chen S
    Transplant Proc; 2006 Dec; 38(10):3312-4. PubMed ID: 17175258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of HLA-G1 protection of porcine endothelial cells against human NK cell cytotoxicity.
    Wang SS; Han JY; Wu XW; Cao RH; Qi HG; Xia ZX; Chen D; Gong FL; Chen S
    Transplant Proc; 2004 Oct; 36(8):2473-4. PubMed ID: 15561285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
    Lilienfeld BG; Crew MD; Forte P; Baumann BC; Seebach JD
    Xenotransplantation; 2007 Mar; 14(2):126-34. PubMed ID: 17381687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on human leukocyte antigen G1 reducing xeno-cell-rejection by transfecting porcine endothelial cells].
    Xia Z; Han J; Wang S; Zeng R; Zhu M; Qi H; Chen D; Wu X; Gong F; Chen S
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Jun; 19(6):486-9. PubMed ID: 16038470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-E/human beta2-microglobulin transgenic pigs: protection against xenogeneic human anti-pig natural killer cell cytotoxicity.
    Weiss EH; Lilienfeld BG; Müller S; Müller E; Herbach N; Kessler B; Wanke R; Schwinzer R; Seebach JD; Wolf E; Brem G
    Transplantation; 2009 Jan; 87(1):35-43. PubMed ID: 19136889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HLA-G1 molecule expressed by ECV304 cells inhibit cytotoxic activity of allogeneic NK cells].
    Zhang CE; Han JY; Yang HJ; Wu XW; Huang YF; Liang ZH; Gong FL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Nov; 21(6):676-8. PubMed ID: 16256023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An HLA-E single chain trimer inhibits human NK cell reactivity towards porcine cells.
    Crew MD; Cannon MJ; Phanavanh B; Garcia-Borges CN
    Mol Immunol; 2005 Jun; 42(10):1205-14. PubMed ID: 15829309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the leader peptide sequence of the HLA-E gene up-regulates its expression and down-regulates natural killer cell-mediated swine endothelial cell lysis.
    Matsunami K; Miyagawa S; Nakai R; Yamada M; Shirakura R
    Transplantation; 2002 May; 73(10):1582-9. PubMed ID: 12042643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytomegalovirus UL18 alleviated human NK-mediated swine endothelial cell lysis.
    Kim JS; Choi SE; Yun IH; Kim JY; Ahn C; Kim SJ; Ha J; Hwang ES; Cha CY; Miyagawa S; Park CG
    Biochem Biophys Res Commun; 2004 Feb; 315(1):144-50. PubMed ID: 15013438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of natural killer cell-mediated swine endothelial cell lysis through genetic remodeling of a glycoantigen.
    Miyagawa S; Nakai R; Yamada M; Tanemura M; Ikeda Y; Taniguchi N; Shirakura R
    J Biochem; 1999 Dec; 126(6):1067-73. PubMed ID: 10578058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility to natural killer cell-mediated cytolysis is independent of the level of target cell class I HLA expression.
    Leiden JM; Karpinski BA; Gottschalk L; Kornbluth J
    J Immunol; 1989 Mar; 142(6):2140-7. PubMed ID: 2493507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The possible use of HLA-G1 and G3 in the inhibition of NK cell-mediated swine endothelial cell lysis.
    Matsunami K; Miyagawa S; Nakai R; Murase A; Shirakura R
    Clin Exp Immunol; 2001 Oct; 126(1):165-72. PubMed ID: 11678914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-Cw3 expression on porcine endothelial cells protects against xenogeneic cytotoxicity mediated by a subset of human NK cells.
    Seebach JD; Comrack C; Germana S; LeGuern C; Sachs DH; DerSimonian H
    J Immunol; 1997 Oct; 159(7):3655-61. PubMed ID: 9317166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-E and HLA-G expression on porcine endothelial cells inhibit xenoreactive human NK cells through CD94/NKG2-dependent and -independent pathways.
    Sasaki H; Xu XC; Mohanakumar T
    J Immunol; 1999 Dec; 163(11):6301-5. PubMed ID: 10570324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HLA-G expression via RNAi abolishes resistance of extravillous trophoblast cell line TEV-1 to NK lysis.
    Chen LJ; Han ZQ; Zhou H; Zou L; Zou P
    Placenta; 2010 Jun; 31(6):519-27. PubMed ID: 20430441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance of HLA-G and HLA-A2 transfectants to lysis by decidual NK cells.
    Chumbley G; King A; Robertson K; Holmes N; Loke YW
    Cell Immunol; 1994 May; 155(2):312-22. PubMed ID: 8181068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of HLA-G boosted natural killer cell-mediated cytolysis in JEG-3 cells cultured in vitro.
    Sun LL; Han Y; Chen JH; Yao YQ
    Fertil Steril; 2008 Dec; 90(6):2398-405. PubMed ID: 18243178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?
    Rouas-Freiss N; Marchal RE; Kirszenbaum M; Dausset J; Carosella ED
    Proc Natl Acad Sci U S A; 1997 May; 94(10):5249-54. PubMed ID: 9144223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class I-like CD1A-C do not protect target cells from NK-mediated cytolysis.
    Storkus WJ; Wei M; Cresswell P; Dawson JR
    Cell Immunol; 1996 Jan; 167(1):154-6. PubMed ID: 8548840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.